Published Date:2022-12-02 Original Link:https://www.onenessbio.com/en/news_detail188_1.htm No 1 Date of announcement 2022/12/02 Time of announcement 20:03:27 Subject The post-market hard-to-heal cases treated by the DFU new drug, Fespixon have been accepted for an oral presentation at 2022 CDS To which item it meets paragraph 12 Date of events 2022/12/04 Statement Date of institutional investor conference:2022/12/04 Time of...Read More